跳至主要内容
临床试验/ITMCTR1900002579
ITMCTR1900002579招募中4 期

Clinical Study for Tongmai Yangxin Pill in Treating Premature Atrial Contraction With Qi and Yin Deficiency Syndrome

The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • 1) In accordance with the above-mentioned diagnostic criteria for Chinese medicine, the syndrome of traditional Chinese medicine belongs to the syndrome of deficiency of Qi and Yin;
  • 2) In line with the above-mentioned Western diagnostic criteria, there are clinical symptoms, and the 24h dynamic electrocardiogram room is greater than or equal to 720 times earlier;
  • 3) Sign the informed consent form;
  • 4) Aged between 18 and 75 years, male or female.

排除标准

  • 1) There are clear predisposing factors, such as infection, electrolyte imbalance (hypokalemia, hypomagnesemia, hyperkalemia);
  • 2) Those who are allergic to the drug ingredients;
  • 3) Patients have other serious liver diseases, heart diseases, kidney diseases, and malignant tumors that affect the evaluation of this study;
  • 4) participated in other drug research within 3 months before using the study drug;
  • 5) Those who have been diagnosed as angina or chest pain caused by acute myocardial infarction, acute heart failure, severe neurosis, hyperthyroidism, gastroesophageal reflux disease and cervical spondylosis;
  • 6) pregnant or lactating women;
  • 7) Combined with severe hypertension (above blood pressure 180 / 110 mmHg), diabetic ketoacidosis, ketoacidosis and severe infection in the past 1 month;
  • 8) The investigator believes that he cannot participate in the clinical trial.

研究者

发起方
The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine

相似试验

Clinical Study for Tongmai Yangxin Pill in Treating... | 临床试验